BG Growth Series - Waga Energy
bethsabee gresse
Welcome to the “BG Growth Series”, where entrepreneurs tell us about their inspiring stories, share invaluable insights, and offer practical tips to navigate the growth journey.
We sat down with Mathieu Lefebvre, Nicolas Paget, Guénaël Prince, three visionary engineers and co-founders of Waga Energy. Their vision? “Biomethane as pillar of the energy transition.”
Waga Energy’s groundbreaking technology – the WAGABOX®, converts landfill gas into biomethane, a carbon-neutral gas which can be used as a renewable substitute for natural gas or injected into the gas grid, offering a sustainable solution for waste management and reducing greenhouse gas emissions.
Learn about their challenges, their moments of triumph, and their relentless drive to make a difference. Discover how their trust in their team and their shared purpose fueled their success, enabling them to scale up their product from small landfills in France to expand to seventeen WAGABOX® units, secure contracts with major waste management companies and local authorities, with ongoing expansion across the USA, Canada, France, and Spain.
Working with Bryan Garnier for the IPO was a fast track to success according to Waga’s co-founder Mathieu Lefebvre. Bryan Garnier notably played a crucial role in convincing the board that Waga Energy was IPO ready.
Waga Energy’s destination is crystal clear; they’ve already saved more than 100,000 tonnes of CO2 from entering the atmosphere, but they’re just getting started.
Join us on this captivating journey and experience how Bryan Garnier, the world’s leading independent full-service investment bank for European healthcare and technology-led companies, contributes to shaping a sustainable future, by partnering with companies like Waga Energy. Bryan Garnier’s commitment to long-term success, deep industry knowledge, and global perspective enable companies to accelerate their growth and make a lasting impact.
Watch this episode of BG Growth Series to learn about Waga’s growth journey and IPO experience.
Rising Stars: Beyond the hype
PARIS October 11th, 2023 – BG IRIS, Bryan Garnier’s research platform, is pleased to release the “Rising Stars: Beyond the hype”, a comprehensive analysis of the space sector and underlying M&A market activities.
NewSpace is not just a buzzword; it’s a transformative force redefining the space industry. In this ever-evolving landscape, private capital is surging, innovation cycles are shrinking, and commercial applications are multiplying. To help investors stay ahead of the curve, we present our analysis of the NewSpace potential and underlying market activities.
Within this comprehensive white paper, we guide investors through the NewSpace landscape, unveil the prevailing trends, and assess the genuine opportunities that lie beyond the hype. Our analysis uncovers challenges and expert opinions that will shape the industry’s future.
We find that while the tech sector’s investment pace has moderated, NewSpace remains resilient. Although capital is becoming scarcer, this shift is leading to more solid grounds for investing. Governmental support remains pivotal, fueled by concerns over sovereignty. The potential for commercial applications remains promising.
To dive deep into this topic and discover how NewSpace is poised to shape the future of the space industry, request the white paper.
Thomas Coudry
BG IRIS
Bryan Garnier Expands in London with Addition of Debt Advisory Director
Nicolas Bucci
Debt Advisory
LONDON, 4 OCTOBER 2023 – Bryan, Garnier & Co, the leading investment bank for healthcare and technology-related companies has announced that Nicolas Bucci has joined the Bank as a Director of Debt Advisory in London.
Nicolas joins from Société Générale in London, where he was a Director in the Leveraged Capital Markets team. Nicolas has over a decade’s experience in the leveraged debt capital markets, specifically originating, structuring and executing high yield bond mandates. Nicolas was covering both sponsor-owned and corporate issuers for transactions ranging from small refinancing to multi-billion acquisition financing. He holds a Master’s in Financial Engineering from Université Panthéon Sorbonne in Paris, France.
Greg Revenu, Co-Founder and Managing Partner at Bryan Garnier & Co, said: “In the current economic climate, our clients need sophisticated financing solutions more than ever before. Nicolas’s appointment is a testimony of our commitment to deepening our debt advisory and capital markets offering. His expertise across global markets ensures that our clients receive advice that is tailored to their financing requirements.”
Nicolas Bucci, Director of Debt Advisory at Bryan Garnier, said: “The focus on collaboration and teamwork at Bryan Garnier to execute challenging and complex transactions is inspiring. I am thrilled to have the opportunity to apply my experience in the leveraged debt markets to develop the debt advisory business and contribute to delivering a comprehensive product offering for clients in some of the most exciting growth sectors in the economy.”
Bryan Garnier is a leading pan-European full-service investment bank. Our debt advisory track record includes transactions such as EasyVista’s unitranche financing by BlackRock; Abivax’s €49 million cross-over financing; Kayrros €15 million venture debt financing; Arturia’s €80 million TLB loan and Agronutris’s €40 million asset backed financing.
Bryan Garnier’s holistic approach to advising clients on the full range of equity, debt and M&A transactions creates a true client-first model, building long-term relationships over the full business lifecycle. As a sector-focused bank since inception, Bryan Garnier specialises in Healthcare, Software & Fintech, Energy Transition and Sustainability, Industrial Tech, Business and Tech-Enabled Services and NextGen Consumer. Bryan Garnier’s mission of investment banking for a better future continues to drive the firm as it backs innovative companies and their investors that are providing solutions to some of the world’s most important challenges.
About Bryan, Garnier & Co
Bryan, Garnier’s is a European growth investment bank helping companies in the healthcare and technology related sectors become global champions. By combining deep sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and leading access to buyers and capital in Europe, US and Asia
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan, Garnier & Co is an independent partnership with around 200 employees located in major financial centers in Europe and the US.
Bryan Garnier Expands Software Investment Banking team with new Managing Director
Valentin Werlé
Software & Fintech
LONDON, 28 September 2023 – Bryan, Garnier & Co, the leading investment bank for European technology and healthcare-related companies has announced that Valentin Werlé has joined as a Managing Director in the Software & Fintech Investment Banking team. Based in London, Valentin will focus on cross-border software M&A advisory across Europe.
Valentin has over a decade of experience within the European tech M&A market. Previously at Arma Partners and William Blair, Valentin advised a large number of leading software companies, notably active in fast-growing segments such as HR-tech, EHS/ESG-tech and cybersecurity, on critical sell-side and fundraising assignments, bringing his deep sector knowledge and robust M&A expertise to founders and tech investors alike. He graduated from Institut d’Etudes Politiques and HEC Paris and holds a MBA from INSEAD.
Greg Revenu, Co-Founder and Managing Partner at Bryan Garnier & Co, said: “Our Software & Fintech practice has consistently ranked among the top European mid-market technology advisors with more than 100 transactions advised over the past ten years. We are very pleased to welcome Valentin whose strong track record in the Software sector will contribute to reinforcing our position in this market, with both trade buyers and financial sponsors.”
Thibaut De Smedt, Partner and Software & Fintech practice lead, said: “We are delighted to welcome Valentin at Bryan Garnier & Co. He brings a wealth of experience with more than a decade of experience in M&A, technical expertise in fast growing Software segments and an extensive global network. His appointment will ensure our clients continue to benefit from sector-specific advice and flawless deal execution.”
Valentin Werlé, Managing Director in Bryan Garnier’s Software & Fintech team said: “I’m thrilled to have joined Bryan Garnier’s Software & Fintech Investment Banking team. The company’s long-lasting commitment to software growth companies aligns with my passion for the sector. I look forward to contributing my experience and knowledge to further develop Bryan Garnier’s highly differentiated platform in key European markets.”
Bryan Garnier is a leader in European software deals. Recent transactions include Ripple’s €250 million acquisition of Metaco; Keensight Capital’s investment in eAttestations, an innovative third-party risk management SaaS platform; Hg Capital’s acquisition of smart mobility and field service management software Nomadia; GPI’s €170 million acquisition of leading player in software solutions for digital healthcare transformation Evolucare; and vehicle logistics pioneer Driiveme’s sale of a minority stake to ISAI Gestion.
Alongside Software & Fintech, Bryan Garnier’s core sectors include Healthcare, Energy Transition and Sustainability, Industrial Tech, Business & Tech-Enabled Services and NextGen Consumer. Bryan Garnier’s mission of investment banking for a better future continues to drive the firm as it backs innovative companies and their investors that are providing solutions to some of the world’s most important challenges.
About Bryan, Garnier & Co
Bryan, Garnier’s is a European growth investment bank helping companies in the healthcare and technology related sectors become global champions. By combining deep sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and leading access to buyers and capital in Europe, US and Asia
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan, Garnier & Co is an independent partnership with around 200 employees located in major financial centers in Europe and the US.
Insects as a sustainable feed ingredient for aquaculture: Sustainable feed critical to meeting global climate targets
PARIS September 27th, 2023 – BG IRIS, Bryan Garnier’s research platform, is pleased to release “Insects as a sustainable feed ingredient for aquaculture: sustainable feed critical to meeting global climate targets”, a comprehensive analysis of the sector and underlying M&A market activities.
As we continue to witness a rise in the world’s population and a shift towards Western-style diets in developing countries, the demand for meat and seafood is projected to surge by a remarkable 70%, reaching 2.0 billion tonnes by 2050, up from 1.2 billion tonnes in 2020.
However, the efficient use of our limited land and water resources remains a critical concern. Our latest white paper dives deep into a pioneering solution: the utilisation of insects as a sustainable source of feed to bolster traditional meat and seafood production. This paper not only uncovers the opportunities and challenges but also provides invaluable insights from industry leaders, painting a comprehensive picture of this emerging sector.
Insect proteins are poised to revolutionise the way we approach compound feed. They offer similar quality and functionalities as soybean and fish meal but with a significantly reduced ecological footprint. The key lies in their circular potential—the remarkable ability of insects to convert farm and off-farm waste streams into valuable products, potentially addressing the staggering fact that one-third of all food production goes to waste.
Our research has honed in on this aspect and revealed a tremendous gap between current insect meal and oil production (30,000 to 40,000 tonnes) and the potential demand, especially within the aquaculture industry, where novel ingredients like insects are highly sought after. The combined demand from pet food and aquaculture feed alone could reach 2.0 million tonnes, with prices exceeding USD 2,000 per tonne, presenting an exciting USD 4.0 billion opportunity for the insect industry in aquaculture feed and pet food.
Furthermore, as prices continue to decrease, the insect ingredient industry’s overall potential could skyrocket beyond USD 20 billion, enticing demand from the poultry and pig industries.
If you’re interested in delving deeper into this groundbreaking topic, this white paper provides a wealth of information on how insect-based solutions are poised to shape the future of sustainable food production.
Nikolaas Faes
Equity Research
Bryan, Garnier & Co Expands NextGen Consumer Corporate Finance Team With New Managing Director Andreas Kulcsar
Andreas Kulcsar
NextGen Consumer
LONDON, 25 September 2023 – Bryan, Garnier & Co, the leading investment bank for European healthcare and technology-related companies, has announced that Andreas Kulcsar has joined the firm as a Managing Director. Based in London, Andreas joins Bryan Garnier’s investment banking team to lead the NextGen Consumer practice.
Andreas has 16 years of cross-border M&A experience and has advised entrepreneurs, blue chip corporate clients, financial sponsors and family offices that are active in the consumer space. Prior to joining Bryan, Garnier & Co, Andreas pursued entrepreneurial ventures and was a senior banker at DC Advisory, where he specialised in transactions in the consumer, food & beverage and specialty retail sectors. He also worked in the corporate finance teams for Commerzbank and Lincoln International, where he worked on both buy and sell side M&A transactions in the consumer and retail sectors, as well as in hospitality and TMT. Andreas holds a Master’s degree in Financial Economics from The American University, Washington, D.C.
Greg Revenu, Co-Founder and Managing Partner at Bryan Garnier & Co, said: “Andreas’ appointment as Managing Director reflects our commitment to attracting top talent as we continue to build on our strong track record in the NextGen Consumer sector. His experience and knowledge in the Consumer, Leisure & Retail sector, as well as advising buy and sell side companies globally, demonstrate our dedication to providing best-in-class advisory services for innovative companies targeting the next generation of consumers.”
Andreas Kulcsar comments: “I am delighted to join Bryan, Garnier & Co as Managing Director, leading the NextGen Consumer sector. Leveraging their track record and comprehensive services offering, I am excited to help current and prospective clients to achieve their strategic goals by working together with the international team and by drawing upon my sector and M&A expertise and relationships.”
Bryan Garnier is a leading advisor to companies and investors in the NextGen Consumer sector, having advised on private placements for companies including Protix, the worldwide market leader in insect-based ingredients, for €50 million, Claranova, an international diversified group of companies operating in key technology sectors, for €65 million, and asgoodasnew, the European circular economy pioneer for premium consumer electronics products, for €18 million. Bryan Garnier also acted as Joint Bookrunner on the €326 million IPO of Mister Spex, a German digitally native omnichannel optician, and as Joint Global Coordinator and Joint Bookrunner for LMK Group, a pioneer in the meal kit space, on their SEK 550 million IPO.
Alongside NextGen Consumer, Bryan Garnier’s core sectors include Energy Transition and Sustainability, Healthcare, Industrial Tech, Software and Fintech, and Business and Tech-Enabled Services. Bryan Garnier’s mission of investment banking for a better future continues to drive the firm as it supports disruptive companies and their investors who are providing solutions to some of the world’s most important challenges.
About Bryan, Garnier & Co
Bryan, Garnier’s is a European growth investment bank helping companies in the healthcare and technology related sectors become global champions. By combining deep sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and leading access to buyers and capital in Europe, US and Asia
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan, Garnier & Co is an independent partnership with around 200 employees located in major financial centers in Europe and the US.
NOR Capital Joins Bryan Garnier
Florent Roulet
Antony Northrop
LONDON, 18 September 2023 – Bryan, Garnier & Co, the leading investment bank for European healthcare and technology-related companies has announced the acquisition of NOR Capital, a London-headquartered pan-European Corporate Finance advisory firm focused on the Technology, Media and Telecom (TMT) sectors.
NOR Capital’s entire team combines with Bryan Garnier’s London office, capitalising on a proven track record of advising companies throughout their life cycle. NOR Capital currently specialises in both M&A and Capital Raising advisory services for private and public companies. NOR Capital adds to Bryan Garnier a strong pan-European client base in the UK and Ireland, the Nordics, German-speaking countries, France and the Benelux, as well as access to relevant investors and corporates globally.
The NOR Capital team’s sector expertise reinforces Bryan, Garnier & Co’s Technology team, especially around the verticals of Fintech & Insurtech, Mobility, Space, Internet of Things, E-commerce, Marketplaces and Media & Entertainment.
Antony Northrop and Florent Roulet, who co-founded NOR Capital in late 2014, both bring to Bryan Garnier a wealth of experience, advising from both early-stage to large global firms, as part of sector-focused boutique advisory firms and large international investment banks. Florent, who started his career at Bryan, Garnier & Co in 2007, also worked in the TMT industry at Bank of America Merrill Lynch, UBS and GP Bullhound. He holds a Master of Science in Corporate Finance from EM Lyon. Antony, who started his career at J.P. Morgan, was previously a Partner at Lazard and an Executive Committee member at SBCI / UBS. Antony also founded M&A boutique Touchstone Securities, which subsequently became part of GP Bullhound. He holds a Master of Arts in Politics, Philosophy and Economics from the University of Oxford.
Florent Roulet, Co-Founder of NOR Capital, said: “Rejoining Bryan, Garnier & Co as a Partner is a true full-circle moment. We are excited to unite our proven expertise with the extensive resources and global reach of Bryan Garnier’s comprehensive platform. Together, we are primed to deliver outstanding results, not just for our current clients, but for the boundless opportunities on the horizon.”
Antony Northrop, Co-Founder of NOR Capital, said: “Our respective firms share an entrepreneurial zeal and relentless commitment to executing complex transactions to help clients achieve their growth ambitions. We look forward to leveraging our combined experience and Bryan Garnier’s full-service product offering and global footprint to best serve our existing and future advisory clients.”
Olivier Garnier, Founder and Managing Partner of Bryan Garnier, said: “This acquisition underscores our commitment to the London market. NOR Capital is a recognised sector-focused investment banking boutique with a demonstrable history of advising exciting growth companies at the forefront of technological innovation, complementing our expertise and relationships with companies and investors across various sectors and geographies. In addition, the NOR Capital team’s entrepreneurial spirit means that they are the perfect addition to Bryan Garnier and together we will continue to build on our strong track record in London and across Europe.”
Bryan Garnier has advised on multiple sector-defining deals in healthcare and technology-related sectors. Recent transactions include the EUR 250m sale of leading crypto custody firm Metaco to Ripple Labs in May 2023, green hydrogen producer Lhyfe’s EUR 110m IPO on Euronext Paris in May 2022 and Carbios’ EUR 141m Rights Issue in July 2023.
Bryan Garnier’s core sectors are Healthcare, Software & Fintech, Industrial Tech, Energy Transition & Sustainability, Business and Tech-Enabled Services and NextGen Consumer. Bryan Garnier’s mission of investment banking for a better future continues to drive the firm as it backs innovative companies and their investors that are providing solutions to some of the world’s most important challenges.
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European growth investment bank helping companies in the healthcare and technology-related sectors become global champions. By combining deep sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and leading access to buyers and capital in Europe, the US and Asia.
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan, Garnier & Co is an independent partnership with over 200 employees located in major financial centres in Europe and the US.
About NOR Capital
NOR Capital is a pan-European Corporate Finance advisory firm focused on the Technology, Media and Telecom (TMT) sectors. Over the years, NOR Capital has advised on a wide range of transactions, with core services centred around M&A, Capital Raising and Strategic Advisory.
NOR Capital operates with a team of TMT sector experts who have experience from both large bulge bracket investment banks and leading sector-focused advisory firms. With a strong track-record of successfully advising on a number of transactions, NOR Capital is recognised as both industry and deal execution experts, having many years of relevant deal experience and demonstrating multiple repeat client relationships.
Fermentation, Mycoprotein, Cellular Agriculture: Sustainable solutions for food production
PARIS September 12th, 2023 – BG IRIS, Bryan Garnier’s research platform, is pleased to release the “Fermentation, Mycoprotein, Cellular Agriculture: Sustainable solutions for food production”, a comprehensive analysis of the sector and underlying M&A market activities.
By 2050, global food production is set to skyrocket by 70%, with an astonishing 78% surge in protein demand. The world needs urgent and innovative solutions to meet this unprecedented challenge while ensuring food safety and nutrition.
Building on extensive research and conversation with key innovators in the field, this paper comprehensively examines a range of fermentation technologies: encompassing traditional and precision fermentation, mycelium, and cellular agriculture.
These techniques can sustainably produce innovative ingredients, replicate animal proteins, and create new food products, with additional consumer applications in beauty and fashion.
Despite the EUR3.7 billion raised by industry pioneers in 2021 and 2022, the journey ahead demands double that investment to unleash the full potential.
However, regulatory and infrastructural challenges, particularly in Europe, hinder progress, as safety authorities lag behind their global peers in Novel Foods adoption. To address this, less than 1% of bioreactor capacity needed for food fermentation is expected to be live by 2030 globally, necessitating collaborative efforts among governments, corporations, and investors to support start-up growth.
For investors seeking data-driven insights into these transformative industries, our white paper is an essential resource. Download it to explore investment opportunities in fermentation, mycoprotein, and cellular agriculture and shape the future of sustainable food production.
Philippine Adam
BG IRIS
Julien Polenne Joins Bryan, Garnier & Co to Lead Private Capital Markets Team
Julien Polenne
Private Capital Markets
PARIS, 5 September 2023 – Bryan, Garnier & Co, the leading investment bank for European healthcare and technology-related companies, has announced that Julien Polenne has joined the firm as a Managing Director to spearhead its Private Capital Markets advisory practice in Europe. Based in Paris, Julien will capitalise on his experience to reinforce the firm’s equity private placements offering.
With more than 20 years of experience in various roles of equity and debt advisory and strategic consulting Julien is a strong addition to Bryan Garnier & Co. He comes from BNP Paribas CIB, where he established and headed their Private Placements Advisory team that helped European fast growing innovative companies on non-control minority equity and equity-linked issuances. Before that, Julien has steered the strategic transformation of BNP Paribas Investment Banking business lines with a focus on organisational and structural value creation, digitalisation and cultural change. Julien was previously an Investment Banking Director based in Hong Kong and Singapore, with a specialisation in Structured Debt and Financial Advisory.
Greg Revenu, Co-Founder and Managing Partner at Bryan Garnier & Co, said: “Julien’s appointment as Managing Director will further strengthen our equity private placements offering. He brings a strategic vision and proven ability to build teams designed to centre and service the client of the future. His extensive expertise and network ensure our clients have the complete package of resources and access unique in this marketplace.”
Julien Polenne comments, Managing Director in Bryan Garnier’s Private Capital Markets team said: “The new technologies are creating amazing opportunities for the industry, the models, and our society. I am thrilled to be part of Bryan, Garnier & Co and its innovative DNA. I can’t wait to work with the Private Capital Markets team and leverage their agility, enthusiasm, and passion for innovation. By expanding the team together, I intend to apply my expertise in industrialization, structuring, and strategic leadership to support our clients in reaching their long-term goals and success.”
Bryan, Garnier & Co is a leading advisor to companies and investors in private placements and has accumulated one of the most significant track-records in Europe, having led some of the largest fundraisings for fast-growing clients using a variety of financial structures and at all stages of development, from venture to pre-IPO or PIPEs. Recent transactions in the space include MedinCell’s €25 million Follow-on Offering; recycled PVB innovator Shark Solutions’ €20 million private placement; insect-based ingredients company Protix on its €50 million equity funding round; alternative protein pioneer Agronutris’s €100m fundraising; and leading digital communication software provider Groupe Positive’s €110m fundraising.
Bryan, Garnier & Co offers a complete range of investment banking services, from private and public growth financing to mergers and acquisitions. Bryan Garnier’s core sectors include Energy Transition and Sustainability, Healthcare, Industrial Tech, Software and Fintech, NextGen Consumer and Business and Tech-Enabled Services. Bryan Garnier’s mission of investment banking for a better future continues to drive the firm as it supports disruptive companies and their investors who are providing solutions to some of the world’s most important challenges.
The Steady Growth and Resilience of the TIC Sector: Exploring Future Trends and Investment Opportunities
Ysée Long
Testing, Inspection, and Certification (TIC)In the ever-shifting landscape of industries, one sector stands firm as an unwavering anchor.
Unfazed by the tumultuous waves of change, this sector has not only showcased exceptional resilience during the Covid-19 pandemic but has also maintained an impressive trajectory of steady growth. Bolstered by three promising megatrends, the TIC sector is poised for an exciting expansion in the years to come.
The Indispensable Role of the TIC Sector Across Industries
Embedded within a myriad of industries – from construction and manufacturing to food, agriculture, energy, and chemicals – the TIC sector holds an irreplaceable position in ensuring the safety, quality, and dependability of products and services. Its role is pivotal in safeguarding public health and safety, environmental integrity, and consumer trust. This sector’s resilience is deeply rooted in its extensive range of services and its critical function, making it a reliable bedrock even in times of unprecedented crisis.
Navigating Uncertainty: Resilience of TIC Companies Amidst Challenges
Despite the havoc wreaked by the Covid-19 pandemic across various sectors, major listed TIC companies emerged as beacons of resilience in 2020. Remarkably, these companies maintained a relatively stable EBITDA margin despite experiencing a dip in revenue. This steadfastness serves as a testament to their adaptability in the face of unexpected hurdles and their prowess in responding to market shifts.
Fundamental Growth Drivers in the TIC Sector
Fueling the sector’s steadfast growth is an ongoing trend towards outsourcing. Fueled by a convergence of cost-saving incentives and regulatory demands for independence, independent TIC companies are steadily ascending. Notably, current statistics indicate that independent players in the TIC sector hold around 40% of the total conformity assessment market, with the remaining 60% shared between insourced entities and governmental bodies.
The TIC sector’s growth is further propelled by stringent regulatory mandates pertaining to quality, safety, and environmental impact. Moreover, as consumer awareness about quality, safety, and sustainability escalates – particularly within the realms of food and pharmaceuticals – this heightened consciousness becomes a pivotal driver of the sector’s ongoing expansion.
Looking to the Future: ESG solutions, industrial relocation and digitization
On the horizon, three transformative mega-trends are poised to propel the sector’s growth into overdrive. First and foremost, the soaring demand for Environmental, Social, and Governance (ESG) solutions, both from existing and potential clients, is set to reshape the landscape. Secondly, the rise of industrial relocation offers fresh avenues to fortify supply chains, opening doors for the TIC sector to play an instrumental role. Lastly, as a technological and digital metamorphosis engulfs industries far and wide, the TIC sector stands to reap significant benefits from this ongoing transformation.
Charting the Path Forward: The TIC Sector's Unwavering Momentum
Looking ahead to the upcoming years, the TIC sector demonstrates an unwavering momentum, even amid the global backdrop of geopolitical tensions, labor scarcities, and pandemic-induced lockdowns. Major TIC companies listed on the global stage continue to flourish, cultivating revenue growth and stable EBITDA margins. This remarkable performance underscores their resilience and capacity to navigate a volatile marketplace.
Partnering for Progress: Bryan Garnier's Role in the TIC Sector
At Bryan Garnier, our commitment to supporting companies in high-growth, dynamic sectors like TIC is unwavering. Armed with deep-seated industry expertise, a global perspective, and a comprehensive service platform, we stand poised to equip our clients with the insights and tools essential for their success. As we gaze into the future, we are excited to stand shoulder-to-shoulder with our clients as they navigate this ever-evolving landscape and emerge as true global frontrunners.
Investor Insight: Tapping into the TIC Sector's Potential
The key takeaway for potential investors is crystal clear: the Testing, Inspection, and Certification (TIC) sector presents robust prospects and commendable resilience. With the mounting demand for ESG solutions, the surge in industrial relocations promising supply chain security, and the pervasive digital transformation sweeping industries, the sector’s growth trajectory seems unstoppable. Additionally, the TIC sector is projected to attain a valuation exceeding EUR 250 billion by 2025, accompanied by a projected Compound Annual Growth Rate (CAGR) of 4.6%. This alluring potential positions the sector as an attractive investment opportunity with the possibility of mergers and acquisitions further fueling fragmentation.